SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as investors discuss its potential for a short squeeze and future growth, fueled by news of Goldman Sachs taking a significant stake in the company. Community members are actively debating the impact of upcoming warrants and a possible shift in market sentiment, while also highlighting the company's potential within the evolving real estate landscape. Bullish sentiment appears to be growing, with many looking ahead to earnings.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending as investors anticipate upcoming earnings, with discussions focusing on revenue beats versus EPS concerns due to ongoing capital expenditures. Community sentiment is mixed, with some expressing long-term bullishness while others are wary of a potential negative earnings reaction and insider selling. The stock's volatility and the broader AI data center sector are also key talking points.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health ($OSCR) is trending as the market weighs the potential impact of ACA subsidy changes and government shutdown negotiations on the healthcare sector. Community discussions revolve around whether Trump's proposed shift to direct subsidies favors Oscar's model, while others express concerns about potential premium increases and reduced coverage. Investors are also anticipating the company's upcoming earnings report, evaluating its growth trajectory and path to profitability amid these uncertainties.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors discuss the potential for profitability amid delivery numbers and JPMorgan's reduced holdings. The community is actively debating market manipulation and whether NIO's management is effectively rewarding long-term investors. There are also discussions around NIO's battery swap technology and its competitive positioning against companies like XPEV, Tesla and BYD.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending downwards as the community discusses concerns around debt, insider selling, and the feasibility of AI initiatives following a large post-earnings surge. Investors are closely watching management's response to market skepticism and rumors, with some expressing frustration over the lack of communication. There's also chatter about the stock potentially filling a gap and what this could mean for future price movement.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to anticipation surrounding the upcoming data release from its Hope-3 trial, a pivotal study for its DMD treatment. Community discussions revolve around potential outcomes, statistical significance, and the FDA's regulatory flexibility, with some expressing concerns about short selling. Broader interest exists due to Capricor's potential to address an unmet need in treating Duchenne Muscular Dystrophy, a rare and serious disease.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors await the outcome of an oral explanation meeting with the EMA regarding its Alzheimer's drug, Blarcamesine, with potential approval news expected soon. Community discussions revolve around speculation on who will present at the meeting and the impact of the oral explanation on approval odds, with some expressing concerns about the recent stock decline. Despite the uncertainty, many remain optimistic about the drug's potential and are anticipating a decision.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a significant price surge, reportedly fueled by a recent acquisition and a large private placement. Community discussions revolve around the potential for a short squeeze, given the stock's low float and high cost to borrow, while others caution about potential dilution and overvaluation. Traders are closely monitoring trading halts and volatility, with some anticipating further upward momentum and others expecting a pullback.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as the healthcare sector faces political pressure amid ongoing debates around ACA subsidies and government shutdowns, leading to community discussions about potential impacts on insurance companies. Some traders are speculating on possible government intervention and its effect on UNH's financials, while others focus on upcoming catalysts such as the 13F filings and investor conferences. The community is closely watching for signals of a bottom after a sustained downtrend.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is experiencing increased interest fueled by upcoming presentations at the AASLD Liver Meeting, where new biomarker data and trial results will be shared. The community is actively discussing the potential of Belapectin, particularly its use in combination with GLP-1 drugs, and the possibility of a short squeeze due to the stock's high short interest. Speculation around a potential partnership or buyout before the year-end is also contributing to the current buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
